Literature DB >> 18205792

Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells.

Zhe Shi1, Muhaimin Rifa'i, Young Ho Lee, Hiroshi Shiku, Ken-Ichi Isobe, Haruhiko Suzuki.   

Abstract

CD8+CD122+ regulatory T cells are a newly identified, naturally occurring type of regulatory T cell that produce interleukin-10 (IL-10) and effectively suppress interferon-gamma (IFN-gamma) production from both CD8+ and CD4+ target cells. Molecular mechanisms responsible for the recognition of target cells by CD8+CD122+ regulatory T cells were investigated in this study by using an in vitro culture system that reconstitutes the regulatory action of these cells. CD8+CD122( regulatory T cells did not produce IL-10 and did not suppress the IFN-gamma production of allogeneic target T cells when they were stimulated by immobilized anti-CD3 antibody alone, but they clearly produced IL-10 and suppressed the IFN-gamma production of target cells when stimulated by anti-CD3 plus anti-CD28-coated beads. IFN-gamma production by major histocompatibility complex-class I-deficient T cells was also suppressed by CD8+CD122+ regulatory T cells stimulated with anti-CD3 plus anti-CD28 antibody but was not suppressed by cells stimulated by anti-CD3 alone. Experiments examining the blockade of cell surface molecules expressed on either the regulatory cells or the target cells by adding specific neutralizing antibodies in the culture indicated that CD80, CD86, and CD28 molecules were involved in the regulatory action, but cytotoxic T lymphocyte antigen-4, inducible costimulatory molecule (ICOS) and programmed death-1 (PD-1) molecules were not. Finally, CD8+CD122+ cells isolated from CD28-knockout (CD28-/-) mice showed no regulatory activity. These results indicate that CD8+CD122(+) regulatory T cells recognize target T cells via the interaction of CD80/CD86-CD28 molecules to become active regulatory cells that produce suppressive factors such as IL-10.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205792      PMCID: PMC2434386          DOI: 10.1111/j.1365-2567.2007.02747.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.

Authors:  Qizhi Tang; Elisa K Boden; Kammi J Henriksen; Helene Bour-Jordan; Mingying Bi; Jeffrey A Bluestone
Journal:  Eur J Immunol       Date:  2004-11       Impact factor: 5.532

2.  Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis.

Authors:  P J Perrin; C H June; J H Maldonado; R B Ratts; M K Racke
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

3.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation.

Authors:  F Borriello; M P Sethna; S D Boyd; A N Schweitzer; E A Tivol; D Jacoby; T B Strom; E M Simpson; G J Freeman; A H Sharpe
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

4.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

Authors:  T Takahashi; Y Kuniyasu; M Toda; N Sakaguchi; M Itoh; M Iwata; J Shimizu; S Sakaguchi
Journal:  Int Immunol       Date:  1998-12       Impact factor: 4.823

5.  Role of CD28 in acute graft-versus-host disease.

Authors:  X Z Yu; P J Martin; C Anasetti
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

6.  Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells.

Authors:  Z Liu; S Tugulea; R Cortesini; N Suciu-Foca
Journal:  Int Immunol       Date:  1998-06       Impact factor: 4.823

7.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.

Authors:  H Suzuki; T M Kündig; C Furlonger; A Wakeham; E Timms; T Matsuyama; R Schmits; J J Simard; P S Ohashi; H Griesser
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

8.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

9.  Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis.

Authors:  Muhaimin Rifa'i; Yoshiyuki Kawamoto; Izumi Nakashima; Haruhiko Suzuki
Journal:  J Exp Med       Date:  2004-11-01       Impact factor: 14.307

10.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  19 in total

1.  CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity.

Authors:  Kazuyuki Akane; Seiji Kojima; Tak W Mak; Hiroshi Shiku; Haruhiko Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-11       Impact factor: 11.205

Review 2.  CD8(+) Tregs in autoimmunity: learning "self"-control from experience.

Authors:  Sue Tsai; Xavier Clemente-Casares; Pere Santamaria
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

3.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  CD8+ Tregs in lupus, autoimmunity, and beyond.

Authors:  Ravi K Dinesh; Brian J Skaggs; Antonio La Cava; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-10       Impact factor: 9.754

Review 5.  A naturally occurring CD8(+)CD122(+) T-cell subset as a memory-like Treg family.

Authors:  Shanshan Li; Qingfeng Xie; Yuqun Zeng; Chuan Zou; Xusheng Liu; Shouhai Wu; Haixia Deng; Yang Xu; Xian C Li; Zhenhua Dai
Journal:  Cell Mol Immunol       Date:  2014-05-05       Impact factor: 11.530

6.  Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.

Authors:  Ashutosh K Mangalam; David Luckey; Shailendra Giri; Michele Smart; Larry R Pease; Moses Rodriguez; Chella S David
Journal:  J Autoimmun       Date:  2012-03-28       Impact factor: 7.094

7.  Antibiotics protect against EAE by increasing regulatory and anti-inflammatory cells.

Authors:  Hilary A Seifert; Gil Benedek; Ha Nguyen; Grant Gerstner; Ying Zhang; Gail Kent; Arthur A Vandenbark; Jürgen Bernhagen; Halina Offner
Journal:  Metab Brain Dis       Date:  2018-06-18       Impact factor: 3.584

8.  Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation.

Authors:  María Emilia Solano; Mirka Katharina Kowal; Greta Eugenia O'Rourke; Andrea Kristina Horst; Kathrin Modest; Torsten Plösch; Roja Barikbin; Chressen Catharina Remus; Robert G Berger; Caitlin Jago; Hoang Ho; Gabriele Sass; Victoria J Parker; John P Lydon; Francesco J DeMayo; Kurt Hecher; Khalil Karimi; Petra Clara Arck
Journal:  J Clin Invest       Date:  2015-03-16       Impact factor: 14.808

9.  Significance of propolis administration for homeostasis of CD4(+)CD25(+) immunoregulatory T cells controlling hyperglycemia.

Authors:  Muhaimin Rifa'i; Nashi Widodo
Journal:  Springerplus       Date:  2014-09-15

10.  Editorial: Memory T Cells: Effectors, Regulators, and Implications for Transplant Tolerance.

Authors:  Yu-Qun Zeng; Chuanjian Lu; Zhenhua Dai
Journal:  Front Immunol       Date:  2016-01-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.